The effect of Wellsolve, a novel solubilizing agent, on the intestinal barrier function and intestinal absorption of griseofulvin in rats

The effect of Wellsolve, a new solubilizing agent, on the function of intestinal membrane barrier and transporters including P-glycoprotein (P-gp) and peptide transporter (PEPT1) was examined by an in vitro diffusion chamber and an in situ closed loop method. The model drugs used in this study were...

Full description

Bibliographic Details
Published in:Biological and Pharmaceutical Bulletin
Main Author: Hamid K.A.; Lin Y.; Gao Y.; Katsumi H.; Sakane T.; Yamamoto A.
Format: Article
Language:English
Published: 2009
Online Access:https://www.scopus.com/inward/record.uri?eid=2-s2.0-70350743125&doi=10.1248%2fbpb.32.1898&partnerID=40&md5=ea8639405cfdd49c1f9bae17edcc2fc3
id 2-s2.0-70350743125
spelling 2-s2.0-70350743125
Hamid K.A.; Lin Y.; Gao Y.; Katsumi H.; Sakane T.; Yamamoto A.
The effect of Wellsolve, a novel solubilizing agent, on the intestinal barrier function and intestinal absorption of griseofulvin in rats
2009
Biological and Pharmaceutical Bulletin
32
11
10.1248/bpb.32.1898
https://www.scopus.com/inward/record.uri?eid=2-s2.0-70350743125&doi=10.1248%2fbpb.32.1898&partnerID=40&md5=ea8639405cfdd49c1f9bae17edcc2fc3
The effect of Wellsolve, a new solubilizing agent, on the function of intestinal membrane barrier and transporters including P-glycoprotein (P-gp) and peptide transporter (PEPT1) was examined by an in vitro diffusion chamber and an in situ closed loop method. The model drugs used in this study were 5(6)-carboxyfluorescein (CF), rhodamine123 (a P-glycoprotein substrate), cephalexin (a typical substrate for PEPT1) and griseofulvin (a BCS Class II drug). Intestinal absorption of CF was not affected by the addition of 1-10% (v/v) Wellsolve, while 20% (v/v) Wellsolve significantly enhanced its intestinal absorption by the in situ absorption study. Therefore, this finding suggested that high concentration of Wellsolve might alter the intestinal barrier function. The mucosal to serosal (absorptive) and serosal to mucosal (secretory) transport of rhodamine123 was significantly inhibited in the presence of 5.0-20% (v/v) of Wellsolve, suggesting that Wellsolve might not affect the function of P-gp in the intestine. The intestinal transport of cephalexin was not affected in the presence of Wellsolve, suggesting that this solubilizing agent might not change the function of PEPT1 in the intestine. In the toxicity studies, we found that 1-10% (v/v) Wellsolve did not change the release of lactate hydrogenase (LDH) and protein from the intestinal membranes. Furthermore, intestinal absorption of griseofulvin in the presence of 10% (v/v) Wellsolve significantly increased as compared with the control. In summary, Wellsolve at lower concentrations might be a potent and safe solubilizing agent for improving the solubility and absorption of poorly water-soluble drugs including griseofulvin. © 2009 Pharmaceutical Society of Japan.

13475215
English
Article
All Open Access; Bronze Open Access
author Hamid K.A.; Lin Y.; Gao Y.; Katsumi H.; Sakane T.; Yamamoto A.
spellingShingle Hamid K.A.; Lin Y.; Gao Y.; Katsumi H.; Sakane T.; Yamamoto A.
The effect of Wellsolve, a novel solubilizing agent, on the intestinal barrier function and intestinal absorption of griseofulvin in rats
author_facet Hamid K.A.; Lin Y.; Gao Y.; Katsumi H.; Sakane T.; Yamamoto A.
author_sort Hamid K.A.; Lin Y.; Gao Y.; Katsumi H.; Sakane T.; Yamamoto A.
title The effect of Wellsolve, a novel solubilizing agent, on the intestinal barrier function and intestinal absorption of griseofulvin in rats
title_short The effect of Wellsolve, a novel solubilizing agent, on the intestinal barrier function and intestinal absorption of griseofulvin in rats
title_full The effect of Wellsolve, a novel solubilizing agent, on the intestinal barrier function and intestinal absorption of griseofulvin in rats
title_fullStr The effect of Wellsolve, a novel solubilizing agent, on the intestinal barrier function and intestinal absorption of griseofulvin in rats
title_full_unstemmed The effect of Wellsolve, a novel solubilizing agent, on the intestinal barrier function and intestinal absorption of griseofulvin in rats
title_sort The effect of Wellsolve, a novel solubilizing agent, on the intestinal barrier function and intestinal absorption of griseofulvin in rats
publishDate 2009
container_title Biological and Pharmaceutical Bulletin
container_volume 32
container_issue 11
doi_str_mv 10.1248/bpb.32.1898
url https://www.scopus.com/inward/record.uri?eid=2-s2.0-70350743125&doi=10.1248%2fbpb.32.1898&partnerID=40&md5=ea8639405cfdd49c1f9bae17edcc2fc3
description The effect of Wellsolve, a new solubilizing agent, on the function of intestinal membrane barrier and transporters including P-glycoprotein (P-gp) and peptide transporter (PEPT1) was examined by an in vitro diffusion chamber and an in situ closed loop method. The model drugs used in this study were 5(6)-carboxyfluorescein (CF), rhodamine123 (a P-glycoprotein substrate), cephalexin (a typical substrate for PEPT1) and griseofulvin (a BCS Class II drug). Intestinal absorption of CF was not affected by the addition of 1-10% (v/v) Wellsolve, while 20% (v/v) Wellsolve significantly enhanced its intestinal absorption by the in situ absorption study. Therefore, this finding suggested that high concentration of Wellsolve might alter the intestinal barrier function. The mucosal to serosal (absorptive) and serosal to mucosal (secretory) transport of rhodamine123 was significantly inhibited in the presence of 5.0-20% (v/v) of Wellsolve, suggesting that Wellsolve might not affect the function of P-gp in the intestine. The intestinal transport of cephalexin was not affected in the presence of Wellsolve, suggesting that this solubilizing agent might not change the function of PEPT1 in the intestine. In the toxicity studies, we found that 1-10% (v/v) Wellsolve did not change the release of lactate hydrogenase (LDH) and protein from the intestinal membranes. Furthermore, intestinal absorption of griseofulvin in the presence of 10% (v/v) Wellsolve significantly increased as compared with the control. In summary, Wellsolve at lower concentrations might be a potent and safe solubilizing agent for improving the solubility and absorption of poorly water-soluble drugs including griseofulvin. © 2009 Pharmaceutical Society of Japan.
publisher
issn 13475215
language English
format Article
accesstype All Open Access; Bronze Open Access
record_format scopus
collection Scopus
_version_ 1809677914923335680